
A study led by UC Irvine oncologist Dr. Rita Mehta and conducted by the Southwest Oncology Group found postmenopausal women with the most common type of metastatic breast cancer can now live longer with a new treatment option. The findings appear in the Aug. 2 issue of the iNew England Journal of Medicine/i. A combination of the two anti-estrogen drugs anastrozole and fulvestrant extended the median survival time of women with Stage 4 hormone receptor-positive ...

via Medindia Health News
More READ

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/08/drug-combo-helps-women-with-common.html
No comments:
Post a Comment